Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Repolar Pharmaceuticals Oy
OY
Active
Y-tunnus 2012066-7
Nihtisillantie 3, 02630
Espoo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2006 · 20 years old
6 employees
www.repolar.com
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Repolar Pharmaceuticals Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
1M
2M
3M
5M
2M
2020
2M
2021
3M
2022
3M
2023
4M
2024
EBITDA
EUR millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
2 156
2 439
2 839
3 216
3 517
Staff expenses
−408
−365
−471
−385
−448
EBITDA
691
542
879
1 037
1 011
Depreciation & amort.
−15
−14
−120
−65
−49
EBIT
676
528
759
972
961
Net financials
0
−0
−1
40
621
Profit before tax
676
528
758
1 011
1 582
Tax
136
106
152
203
320
Net profit
541
422
606
809
1 262
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
1 722
2 104
2 734
3 487
1 739
Equity
1 540
1 839
2 298
2 923
1 339
Long-term debt
—
—
—
0
0
Short-term debt
182
265
436
564
399
Total debt
182
265
436
564
399
Financial ratios
5-year trend
EBITDA margin
28.7%
This company
15.8%
Market median
+82% vs market
2020
2024
Equity ratio
77.0%
This company
38.2%
Market median
+102% vs market
2020
2024
Return on equity
94.2%
This company
18.4%
Market median
+412% vs market
2020
2024
Net profit margin
35.9%
This company
8.1%
Market median
+343% vs market
2020
2024
Asset turnover
2.02×
This company
1.12×
Market median
+80% vs market
2020
2024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on Repolar Pharmaceuticals Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
